Annual EBITDA
-$102.27M$43.14M-72.95%
Summary
- Current Value
- As of today, SVRA annual EBITDA is -$102.27M, down -72.95% on
- Historical Performance
- SVRA annual EBITDA is down -153.36% over the past 3 years, and down -32.66% over the past 5 years
- All-Time High Comparison
- SVRA annual EBITDA is currently -6020.23% below its historical high of -$1.67M set on
- 3-Year Low Comparison
- SVRA annual EBITDA is at its 3-year low
- Sector Comparison
- SVRA annual EBITDA is higher than 16.71% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$102.27M | -73.0% | -153.4% | -32.7% | -812.6% | |
| Quarterly EBITDA | -$30.18M | -14.8% | -187.6% | -182.9% | -1519.7% | |
| TTM EBITDA | -$121.02M | -35.4% | -215.6% | -154.5% | -1190.1% | |
| Price | $5.76 | +89.5% | +231.0% | +339.7% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | -100.0% | |
| Annual EPS | -$0.48 | -46.1% | -50.6% | +75.2% | +99.8% | |
| -$102.40M | -72.9% | -151.4% | -31.1% | -807.3% | ||
| Annual Net Income | -$95.88M | -75.3% | -122.9% | -22.6% | -746.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$37.88M | N/A | -170.0% |
| 5Y | -$37.88M | -170.0% | |
| All | -$1.67M | -6020.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$102.27M | at low | |
| 5Y | -$102.27M | at low | |
| All | -$102.27M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of SVRA?
As of today, SVRA annual EBITDA is -$102.27M
What is 1-year change in SVRA annual EBITDA?
SVRA annual EBITDA is down -72.95% year-over-year
What is 3-year change in SVRA annual EBITDA?
SVRA annual EBITDA is down -153.36% over the past 3 years
How far is SVRA annual EBITDA from its all-time high?
SVRA annual EBITDA is currently -6020.23% below its historical high of -$1.67M set on December 31, 2002
How does SVRA annual EBITDA rank versus sector peers?
SVRA annual EBITDA is higher than 16.71% of companies in Healthcare sector
When is SVRA next annual earnings release?
The next annual earnings release for SVRA is on
Quarterly EBITDA
-$30.18M$1.19M+3.78%
Summary
- Current Value
- As of today, SVRA quarterly EBITDA is -$30.18M, up +3.78% on
- Historical Performance
- SVRA quarterly EBITDA is down -14.80% year-over-year, and down -187.64% over the past 3 years
- All-Time High Comparison
- SVRA quarterly EBITDA is currently -34588.51% below its historical high of -$87.00K set on
- 3-Year Low Comparison
- SVRA quarterly EBITDA is +3.78% above its 3-year low of -$31.37M reached on
- Sector Comparison
- SVRA quarterly EBITDA is higher than 14.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$30.18M | +3.8% | -14.8% | -187.6% | -182.9% | |
| Annual EBITDA | -$102.27M | – | -73.0% | -153.4% | -32.7% | |
| TTM EBITDA | -$121.02M | -3.3% | -35.4% | -215.6% | -154.5% | |
| Price | $5.76 | +66.0% | +89.5% | +231.0% | +339.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | -100.0% | |
| Quarterly EPS | -$0.14 | +2.8% | -19.3% | -100.9% | +25.6% | |
| -$30.26M | +3.8% | -14.8% | -187.2% | -180.5% | ||
| Quarterly Net Income | -$29.56M | +2.8% | -21.9% | -184.6% | -167.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$28.37M | -6.4% | |
| 3Y | -$10.83M | N/A | -178.6% |
| 5Y | -$8.01M | -277.0% | |
| All | -$87.00K | >-9999.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$31.37M | +3.8% | |
| 3Y | -$31.37M | +3.8% | |
| 5Y | -$31.37M | +3.8% | |
| All | -$31.37M | +3.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SVRA?
As of today, SVRA quarterly EBITDA is -$30.18M
What is SVRA quarterly EBITDA most recent change?
SVRA quarterly EBITDA was up +3.78% on September 30, 2025
What is 1-year change in SVRA quarterly EBITDA?
SVRA quarterly EBITDA is down -14.80% year-over-year
How far is SVRA quarterly EBITDA from its all-time high?
SVRA quarterly EBITDA is currently -34588.51% below its historical high of -$87.00K set on December 31, 2002
How does SVRA quarterly EBITDA rank versus sector peers?
SVRA quarterly EBITDA is higher than 14.36% of companies in Healthcare sector
When is SVRA next earnings release?
The next earnings release for SVRA is on
TTM EBITDA
-$121.02M$3.89M-3.32%
Summary
- Current Value
- As of today, SVRA TTM EBITDA is -$121.02M, down -3.32% on
- Historical Performance
- SVRA TTM EBITDA is down -35.39% year-over-year, and down -215.63% over the past 3 years
- All-Time High Comparison
- SVRA TTM EBITDA is currently -38244.74% below its historical high of -$315.60K set on
- 3-Year Low Comparison
- SVRA TTM EBITDA is at its 3-year low
- Sector Comparison
- SVRA TTM EBITDA is higher than 13.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$121.02M | -3.3% | -35.4% | -215.6% | -154.5% | |
| Annual EBITDA | -$102.27M | – | -73.0% | -153.4% | -32.7% | |
| Quarterly EBITDA | -$30.18M | +3.8% | -14.8% | -187.6% | -182.9% | |
| Price | $5.76 | +66.0% | +89.5% | +231.0% | +339.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | 0.0% | -100.0% | |
| TTM EPS | -$0.54 | -4.3% | -22.4% | -90.1% | +59.9% | |
| -$121.30M | -3.3% | -35.3% | -214.2% | -150.8% | ||
| TTM Net Income | -$115.65M | -4.8% | -39.4% | -195.3% | -71.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$102.92M | N/A | -17.6% |
| 3Y | -$38.67M | N/A | -212.9% |
| 5Y | -$37.80M | -220.1% | |
| All | -$315.60K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$121.02M | at low | |
| 3Y | -$121.02M | at low | |
| 5Y | -$121.02M | at low | |
| All | -$121.02M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SVRA?
As of today, SVRA TTM EBITDA is -$121.02M
What is SVRA TTM EBITDA most recent change?
SVRA TTM EBITDA was down -3.32% on September 30, 2025
What is 1-year change in SVRA TTM EBITDA?
SVRA TTM EBITDA is down -35.39% year-over-year
How far is SVRA TTM EBITDA from its all-time high?
SVRA TTM EBITDA is currently -38244.74% below its historical high of -$315.60K set on March 1, 2001
How does SVRA TTM EBITDA rank versus sector peers?
SVRA TTM EBITDA is higher than 13.46% of companies in Healthcare sector
When is SVRA next earnings release?
The next earnings release for SVRA is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- SVRA Official Website www.savarapharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1160308/000119312525277525/0001193125-25-277525-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1160308/000095017025045731/0000950170-25-045731-index.htm
- SVRA Profile on Yahoo Finance finance.yahoo.com/quote/SVRA
- SVRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/svra